Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

322
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
322
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

315
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
315
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

249
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
249
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Drug Therapy01:28

Drug Therapy

325
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
325
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.0K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hernia recurrence postconcurrent hernia repair and metabolic and bariatric surgery versus ventral hernia repair alone.

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery·2026
Same author

Optimising the Delphi survey method during core set development: The impact of summarised feedback on stakeholders' prioritisation of core data items and consensus.

PloS one·2026
Same author

Diabetes-specific formula as meal replacement for individuals with type 2 diabetes mellitus and overweight or obesity: a Singapore expert consensus.

Frontiers in nutrition·2026
Same author

Bariatric Surgery Outcomes in Asians with Severe Obesity (BMI ≥ 50 kg/m<sup>2</sup>).

Journal of clinical medicine·2026
Same author

Navigating the boundary between 'normative' and 'non-normative' collective action: A British case study of the removal of a public statue associated with racism.

The British journal of social psychology·2026
Same author

Relationship between continuous glucose monitoring and corneal neuropathy in type 2 diabetes.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Occupational violence and staff safety in general practice.

Australian family physician·2018
Same journal

You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

Australian family physician·2018
Same journal

Understanding the decision to commence a dose administration aid.

Australian family physician·2018
Same journal

Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

Australian family physician·2018
Same journal

A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

Australian family physician·2018
Same journal

The Australian Mid-West Coastal Marine Wound Infections Study.

Australian family physician·2018
See all related articles

Related Experiment Video

Updated: Feb 26, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.4K

Pharmacotherapy for obesity.

Phong Ching Lee, John Dixon

    Australian Family Physician
    |July 12, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Pharmacotherapy can aid weight loss for obesity management when combined with lifestyle changes. This approach is beneficial for individuals with a high body mass index (BMI) or those with obesity-related health issues.

    More Related Videos

    An Acupoint Catgut-embedding Therapy for Treating Obesity
    04:50

    An Acupoint Catgut-embedding Therapy for Treating Obesity

    Published on: April 4, 2025

    1.7K
    Self-Administration of Drugs in Mouse Models of Feeding and Obesity
    03:37

    Self-Administration of Drugs in Mouse Models of Feeding and Obesity

    Published on: June 8, 2021

    5.2K

    Related Experiment Videos

    Last Updated: Feb 26, 2026

    Multidisciplinary Approach to Obesity Management: A Case Report
    05:10

    Multidisciplinary Approach to Obesity Management: A Case Report

    Published on: May 30, 2025

    1.4K
    An Acupoint Catgut-embedding Therapy for Treating Obesity
    04:50

    An Acupoint Catgut-embedding Therapy for Treating Obesity

    Published on: April 4, 2025

    1.7K
    Self-Administration of Drugs in Mouse Models of Feeding and Obesity
    03:37

    Self-Administration of Drugs in Mouse Models of Feeding and Obesity

    Published on: June 8, 2021

    5.2K

    Area of Science:

    • Medical Science
    • Pharmacology
    • Public Health

    Background:

    • Obesity is a chronic, relapsing disease influenced by genetics and environment.
    • Effective management of obesity requires addressing energy regulation.
    • Pharmacotherapy offers a potential adjunct to lifestyle interventions for weight management.

    Purpose of the Study:

    • To review the role of pharmacotherapy in obesity management.
    • To evaluate the efficacy, side effects, and contraindications of weight-loss medications.

    Main Methods:

    • Literature review of available weight-loss medications.
    • Analysis of pharmacotherapy's role as an adjunct to lifestyle interventions.

    Main Results:

    • Pharmacotherapy can lead to moderate, sustained weight loss.
    • Medications are indicated for individuals with a BMI >30 kg/m² or BMI 27-30 kg/m² with complications.

    Conclusions:

    • Pharmacotherapy is a valuable tool for obesity treatment when integrated with lifestyle changes.
    • Close monitoring of safety and efficacy is crucial during pharmacotherapy.
    • Discontinuation is advised if safety or tolerability issues arise.